Animal & Veterinary
FDA Veterinarian Newsletter January/February 2003 Volume XVIII, No 1
Due to the rapid pace at which science and technology are progressing, leveraging has become essential in optimizing the efficiency of FDA-related activities and for expanding the Agency's resource base. The CRADA is one mechanism through which such leveraging activity may occur. For points to consider and policies regarding the development of a CRADA with the FDA, please refer to http://www.fda.gov/oc/ofacs/partnership/techtran/policyst.htm.
If you have any questions on leveraging or if you have any interest in initiating a collaboration with CVM please contact David Batson at (301) 827-8021.
Dr. Martinez is a Senior Research Scientist in CVM's Office of New Animal Drug Evaluation.
- Presented by Dr. Peter Lee, Associated Director, Pharmacometrics, Office of Clinical Pharmacology and Biopharmaceutics, FDA at the AAPS short course on Computer Simulation and its Role in Drug Development Research, January 28-29, 2002.
- Pharsight News Release, Feb 13, 2001